Quality Tested Third-Party Verified Highly Purified U.S. Based Expert Support
PhysIQ PeptidesPhysIQ Peptides
Back to Shop
Eloralintide 10mg research peptide vial

Eloralintide

Eloralintide

Eloralintide is an investigational, long-acting peptide analog designed to mimic the bioactivity of endogenous amylin while exhibiting enhanced structural stability and pharmacokinetic properties. Native amylin is a 37-amino-acid neuroendocrine hormone co-secreted with insulin by pancreatic beta cells, functioning as a physiological regulator of nutrient influx and satiety.

Due to the rapid clearance and high propensity of native amylin to form insoluble amyloid fibrils, researchers utilize optimized analogs such as Eloralintide to facilitate sustained experimental observation. Structural modifications in Eloralintide prevent self-aggregation, allowing for reproducible in vitro and in vivo studies of amylin receptor pharmacology.

In experimental models, Eloralintide serves as a high-affinity research tool to examine central and peripheral mechanisms governing metabolic homeostasis, body composition modulation, and neuroendocrine signaling networks. All materials are provided exclusively for scientific laboratory evaluation.

Choose how to buy

Your first order ships at the regular price. Every reship after that is 5% off. Pause, change the interval, or cancel anytime.

$228.00per vial · 10mg
Ask a Question
Third-party tested · Purity ≥99% · For laboratory research use only.
Purity
≥99%
Form
Lyophilized powder
Available sizes
10mg

Mechanism of Action

Eloralintide functions as an agonist at amylin receptors (AMYRs), which are formed by heterodimerization of the calcitonin receptor (CTR) core with one of three Receptor Activity-Modifying Proteins (RAMP1, RAMP2, or RAMP3). Activation of these receptor complexes stimulates intracellular cyclic adenosine monophosphate (cAMP) generation and engages downstream kinase cascades.

In preclinical research models, receptor binding in circumventricular organs, particularly the area postrema and the nucleus of the solitary tract, leads to the modulation of central satiety circuits and the deceleration of gastric motility. These signaling events allow researchers to systematically interrogate the molecular pathways controlling appetite suppression, energy expenditure, and glucose-dependent regulatory feedback.

Research Areas

  • ●Amylin receptor subtype pharmacology
  • ●Central neuroendocrine satiety pathways
  • ●Gastric transit and nutrient absorption kinetics
  • ●Metabolic homeostasis and energy balance models
  • ●Comparative peptide stabilization research

Selected References

  • Hay DL et al., Pharmacol Rev (2015)
  • Bower RL et al., Br J Pharmacol (2014)
  • Roth JD et al., Peptides (2012)

Related Products

Epithalon research peptide vial

Epithalon

Purity
99%
Size
50mg
Form
Powder
$75.00Per Unit
FOXO4-DRI research peptide vial

FOXO4-DRI

Purity
≥99%
Size
10mg
Form
Powder
$178.00Per Unit
GHK-Cu research peptide vial

GHK-Cu

Purity
99%
Size
2 sizes
Form
Powder
From $25.00Per Unit
Glutathione research peptide vial

Glutathione

Purity
99%
Size
2 sizes
Form
Powder
From $48.00Per Unit